Cingulate Inc.
CING- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001862150
No open-market purchases or sales by Cingulate Inc. insiders were filed in the last 90 days; 32 institutions reported holding it in 13F filings for Q2 2026, worth $9.88M in total; no superinvestor holds it.
Other share classesCINGW
Q1 2024 vs. Q4 2023
How the institutions holding Cingulate Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 5 | 9 | +4 |
| Shares | 3.81K | 117.9K | +114.1K (+2,997.5%) |
| Value | $29.1K | $128.9K | +$99.8K (+342.8%) |
New holders (4)
Institutions that held Cingulate Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Cowen and Company, LLC | 95,000 | $104.5K | 0.00% |
| HRT Financial LP | 10,689 | $11.0K | 0.00% |
| Advisor Group Holdings, Inc. | 350 | $385 | 0.00% |
| Qube Research & Technologies Ltd | 100 | $110 | 0.00% |
Sold out (0)
Institutions that held Cingulate Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
None.